To put that in perspective, SpaceX alone is targeting a $75 billion capital raise, an amount equivalent to nearly 10% of the average daily stock trading volume in the U.S. markets . When three offerings of this magnitude arrive in a relatively compressed window, it introduces a simple but powerful dynamic: a massive surge in the supply of new shares without a guaranteed proportional increase in demand.
This is the "digestion issue" Brice flagged—the concern that the influx could drain "institutional liquidity" and exert downward pressure on broader indices . Asset management firm GMO, led by legendary investor Jeremy Grantham, issued a similar warning earlier in the year, stating that when substantial new share supply enters the market without corresponding demand increases, prices could drop
.
The risks go beyond simple supply and demand mechanics. Several factors compound the uncertainty:
Profitability concerns: Neither OpenAI nor Anthropic currently generates profits, making their lofty valuations heavily dependent on forward revenue projections holding up . Any miss on growth targets could lead to sharp repricing.
Index concentration: The S&P 500 is already highly concentrated, with just 10 stocks accounting for nearly 40% of the index's value—the highest level since the Great Depression. The addition of three more trillion-dollar tech companies could push that concentration close to 50%, intensifying systemic risk .
Post-lockup selling pressure: Many early investors have been locked into these companies for years. Following the typical six-month lockup period after an IPO, these backers will be free to sell their shares, potentially creating additional downward pressure on stock prices .
Broader market impact: Investors and bankers at a recent AI financing summit warned that poor performance from any of these IPOs could substantially dampen enthusiasm for AI investments across the board . The listings set a public market pricing floor—or ceiling—for the entire sector
.
Standard Chartered's message is one of tactical caution. Brice's framing of the IPOs as a "digestion challenge" implies that the bank sees this wave of listings as a near-term risk factor that warrants a measured response, rather than an opportunity to chase the hype .
Consequently, the bank maintains a cautious stance heading into the summer months, especially given the concentration of these listings in a compressed timeline . The advice aligns with broader warnings that these IPOs represent an "extremely rare event in capital market history" and that the market may need time to find its equilibrium after absorbing such a massive influx of new shares
.
The core takeaway for investors is to watch for near-term turbulence and to approach the IPO hype with patience. While the long-term outlook for AI may remain compelling, the path through this historic wave of public listings is likely to be bumpy.
Comments
0 comments